Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy

Muzahir Tayebjee; Hoong Lim; Robert Macfadyen; Gregory Lip

doi:10.2337/diacare.27.8.2049

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy

Muzahir Tayebjee, Hoong Lim, Robert Macfadyen, Gregory Lip

Research output: Contribution to journal › Article

53 Citations (Scopus)

Original language	English
Pages (from-to)	2049-51
Number of pages	3
Journal	Diabetes Care
Volume	27
Issue number	8
DOIs	https://doi.org/10.2337/diacare.27.8.2049
Publication status	Published - 1 Aug 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/diacare.27.8.2049

Cite this

@article{10e37d9ec7b341c495a27a97199b8ce5,

title = "Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy",

author = "Muzahir Tayebjee and Hoong Lim and Robert Macfadyen and Gregory Lip",

year = "2004",

month = aug,

day = "1",

doi = "10.2337/diacare.27.8.2049",

language = "English",

volume = "27",

pages = "2049--51",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association",

number = "8",

}

TY - JOUR

T1 - Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy

AU - Tayebjee, Muzahir

AU - Lim, Hoong

AU - Macfadyen, Robert

AU - Lip, Gregory

PY - 2004/8/1

Y1 - 2004/8/1

U2 - 10.2337/diacare.27.8.2049

DO - 10.2337/diacare.27.8.2049

M3 - Article

C2 - 15277439

SN - 0149-5992

VL - 27

SP - 2049

EP - 2051

JO - Diabetes Care

JF - Diabetes Care

IS - 8

ER -